Oncology Drugs
Chinese Biotech Growth Forces U.S. Companies to Innovate Faster
David Li, founder of Meliora Therapeutics, quickly learned that the U.S. biotech space isn’t isolated anymore. While looking at drug targets for his new company, he noticed that a lot of the same targets were already being pursued by Chinese firms. Curious, he went to Shanghai and Suzhou. What he saw surprised him. “They’re all…

